Literature DB >> 23879521

Early detection of paracetamol toxicity using circulating liver microRNA and markers of cell necrosis.

James W Dear1, Daniel J Antoine, Philip Starkey-Lewis, Christopher E Goldring, B Kevin Park.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 23879521      PMCID： PMC4004411          DOI： 10.1111/bcp.12214

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  7 in total

1.  RETRACTED: Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity.

Authors:  Daniel J Antoine; Rosalind E Jenkins; James W Dear; Dominic P Williams; Mitchell R McGill; Matthew R Sharpe; Darren G Craig; Kenneth J Simpson; Hartmut Jaeschke; B Kevin Park
Journal:  J Hepatol       Date:  2012-01-17       Impact factor: 25.083

2.  Circulating microRNAs as potential markers of human drug-induced liver injury.

Authors:  Philip J Starkey Lewis; James Dear; Vivien Platt; Kenneth J Simpson; Darren G N Craig; Daniel J Antoine; Neil S French; Neeraj Dhaun; David J Webb; Eithne M Costello; John P Neoptolemos; Jonathan Moggs; Chris E Goldring; B Kevin Park
Journal:  Hepatology       Date:  2011-11       Impact factor: 17.425

3.  High-mobility group box-1 protein and keratin-18, circulating serum proteins informative of acetaminophen-induced necrosis and apoptosis in vivo.

Authors:  Daniel J Antoine; Dominic P Williams; Anja Kipar; Rosalind E Jenkins; Sophie L Regan; Jean G Sathish; Neil R Kitteringham; B Kevin Park
Journal:  Toxicol Sci       Date:  2009-09-25       Impact factor: 4.849

4.  Treating acetaminophen overdose: thresholds, costs and uncertainties.

Authors:  S Gosselin; R S Hoffman; D N Juurlink; I Whyte; M Yarema; J Caro
Journal:  Clin Toxicol (Phila)       Date:  2013-03       Impact factor: 4.467

5.  Circulating microRNAs, potential biomarkers for drug-induced liver injury.

Authors:  Kai Wang; Shile Zhang; Bruz Marzolf; Pamela Troisch; Amy Brightman; Zhiyuan Hu; Leroy E Hood; David J Galas
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-25       Impact factor: 11.205

Review 6.  Management of paracetamol poisoning.

Authors:  Robin E Ferner; James W Dear; D Nicholas Bateman
Journal:  BMJ       Date:  2011-04-19

7.  Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital.

Authors:  Daniel J Antoine; James W Dear; Philip Starkey Lewis; Vivien Platt; Judy Coyle; Moyra Masson; Ruben H Thanacoody; Alasdair J Gray; David J Webb; Jonathan G Moggs; D Nicholas Bateman; Christopher E Goldring; B Kevin Park
Journal:  Hepatology       Date:  2013-07-02       Impact factor: 17.425
  7 in total
  21 in total

Review 1.  MicroRNAs in injury and repair.

Authors:  Cory V Gerlach; Vishal S Vaidya
Journal:  Arch Toxicol       Date:  2017-05-13       Impact factor: 5.153

2.  Outcomes from massive paracetamol overdose: a retrospective observational study.

Authors:  Daniel J B Marks; Paul I Dargan; John R H Archer; Charlotte L Davies; Alison M Dines; David M Wood; Shaun L Greene
Journal:  Br J Clin Pharmacol       Date:  2017-01-25       Impact factor: 4.335

3.  Acetaminophen Hepatotoxicity.

Authors:  Anup Ramachandran; Hartmut Jaeschke
Journal:  Semin Liver Dis       Date:  2019-03-08       Impact factor: 6.115

4.  Blood transcript immune signatures distinguish a subset of people with elevated serum ALT from others given acetaminophen.

Authors:  R D Fannin; K Gerrish; S O Sieber; P R Bushel; P B Watkins; R S Paules
Journal:  Clin Pharmacol Ther       Date:  2016-02-22       Impact factor: 6.875

5.  Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: An international collaborative effort.

Authors:  Rachel J Church; Gerd A Kullak-Ublick; Jiri Aubrecht; Herbert L Bonkovsky; Naga Chalasani; Robert J Fontana; Jens C Goepfert; Frances Hackman; Nicholas M P King; Simon Kirby; Patrick Kirby; John Marcinak; Sif Ormarsdottir; Shelli J Schomaker; Ina Schuppe-Koistinen; Francis Wolenski; Nadir Arber; Michael Merz; John-Michael Sauer; Raul J Andrade; Florian van Bömmel; Thierry Poynard; Paul B Watkins
Journal:  Hepatology       Date:  2018-06-27       Impact factor: 17.425

Review 6.  The transformation in biomarker detection and management of drug-induced liver injury.

Authors:  Rachel J Church; Paul B Watkins
Journal:  Liver Int       Date:  2017-05-08       Impact factor: 5.828

7.  Plasma biomarkers of liver injury and inflammation demonstrate a lack of apoptosis during obstructive cholestasis in mice.

Authors:  Benjamin L Woolbright; Daniel J Antoine; Rosalind E Jenkins; Mary Lynn Bajt; B Kevin Park; Hartmut Jaeschke
Journal:  Toxicol Appl Pharmacol       Date:  2013-10-03       Impact factor: 4.219

8.  Beyond miR-122: Identification of MicroRNA Alterations in Blood During a Time Course of Hepatobiliary Injury and Biliary Hyperplasia in Rats.

Authors:  Rachel J Church; Monicah Otieno; James Eric McDuffie; Bhanu Singh; Manisha Sonee; LeRoy Hall; Paul B Watkins; Heidrun Ellinger-Ziegelbauer; Alison H Harrill
Journal:  Toxicol Sci       Date:  2015-11-26       Impact factor: 4.849

Review 9.  Advances in the Pharmacogenomics of Adverse Drug Reactions.

Authors:  Susannah L Collins; Daniel F Carr; Munir Pirmohamed
Journal:  Drug Saf       Date:  2016-01       Impact factor: 5.606

10.  Methodological considerations for measuring biofluid-based microRNA biomarkers.

Authors:  Brian N Chorley; Elnaz Atabakhsh; Graeme Doran; Jean-Charles Gautier; Heidrun Ellinger-Ziegelbauer; David Jackson; Tatiana Sharapova; Peter S T Yuen; Rachel J Church; Philippe Couttet; Roland Froetschl; James McDuffie; Victor Martinez; Parimal Pande; Lauren Peel; Conor Rafferty; Frank J Simutis; Alison H Harrill
Journal:  Crit Rev Toxicol       Date:  2021-05-26       Impact factor: 6.184
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.